Literature DB >> 13034543

Cortisone in treatment of rheumatoid arthritis.

L E WARD, H F POLLEY, C H SLOCUMB, P S HENCH.   

Abstract

Entities:  

Keywords:  ARTHRITIS, RHEUMATOID/therapy; CORTISONE/therapeutic use

Mesh：

Substances：

Year:  1953        PMID： 13034543     DOI： 10.1001/jama.1953.03690020011003

Source DB:  PubMed          Journal:  J Am Med Assoc        ISSN： 0002-9955


× No keyword cloud information.
  6 in total

1.  Prednisone in rheumatoid arthritis: metabolic and clinical effects.

Authors:  L E WARD; H F POLLEY; M H POWER; H L MASON; C H SLOCUMB; P S HENCH
Journal:  Ann Rheum Dis       Date:  1958-06       Impact factor: 19.103

2.  Management of rheumatoid arthritis with prolonged cortisone administration.

Authors:  W S COPEMAN; O SAVAGE; C DODDS; J H GLYN; M E FEARNLEY
Journal:  Br Med J       Date:  1954-05-15

3.  The indications for cortisone and ACTH in rheumatoid arthritis.

Authors:  W S COPEMAN
Journal:  Proc R Soc Med       Date:  1954-05

4.  Hyaluronidase in Joint Disease.

Authors: 
Journal:  Can Med Assoc J       Date:  1955-07-01       Impact factor: 8.262

5.  Development and implementation of a double-blind corticosteroid-tapering regimen for a clinical trial.

Authors:  Neil Collinson; Katie Tuckwell; Frank Habeck; Monique Chapman; Micki Klearman; John H Stone
Journal:  Int J Rheumatol       Date:  2015-03-24

6.  Cytoprotective gastric pentadecapeptide BPC 157 resolves major vessel occlusion disturbances, ischemia-reperfusion injury following Pringle maneuver, and Budd-Chiari syndrome.

Authors:  Predrag Sikiric; Anita Skrtic; Slaven Gojkovic; Ivan Krezic; Helena Zizek; Eva Lovric; Suncana Sikiric; Mario Knezevic; Sanja Strbe; Marija Milavic; Antonio Kokot; Alenka Boban Blagaic; Sven Seiwerth
Journal:  World J Gastroenterol       Date:  2022-01-07       Impact factor: 5.742
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.